Healthcare News - An Overview
Novo CEO pressed by Senate to chop prices of obesity, diabetic issues medication CEO Lars Fruergaard Jørgensen instructed lawmakers the corporation would think about new talks with insurers concerning the listing costs of Wegovy and copyright should they pledge to maintain the medicines on their own formularies.Expenditure in digital overall healt